Works matching DE "FIDAXOMICIN"

Results: 125

Increases in Anti-infective Drug Prices, Subsequent Prescribing, and Outpatient Costs.

Published in:

JAMA Network Open, 2021, v. 4, n. 6, p. e2113963, doi. 10.1001/jamanetworkopen.2021.13963

By:

Lee, Junsoo;
Joo, Heesoo;
Maskery, Brian A.;
Alpern, Jonathan D.;
Park, Chanhyun;
Weinberg, Michelle;
Stauffer, William M.

Publication type:

Article

Fidaxomicin: novel antibiotic for Clostridium difficile infection.

Published in:

Prescriber, 2013, v. 24, n. 1/2, p. 12, doi. 10.1002/psb.1002

By:

Chaplin, Steve;
Wilcox, Mark

Publication type:

Article

An update on antibody-based immunotherapies for Clostridium difficile infection.

Published in:

Clinical & Experimental Gastroenterology, 2016, v. 9, p. 209, doi. 10.2147/CEG.S84017

By:

Hussack, Greg;
Tanha, Jamshid

Publication type:

Article

Fidaxomicin.

Published in:: Australian Prescriber, 2013, v. 36, n. 4, p. 140
Publication type:: Article

Proteomic Signatures of Clostridium difficile Stressed with Metronidazole, Vancomycin, or Fidaxomicin.

Published in:

Cells (2073-4409), 2018, v. 7, n. 11, p. 213, doi. 10.3390/cells7110213

By:

Maaß, Sandra;
Otto, Andreas;
Albrecht, Dirk;
Riedel, Katharina;
Trautwein-Schult, Anke;
Becher, Dörte

Publication type:

Article

Is There a Future for a Tapered-Pulsed Fidaxomicin Regimen for Pediatric Patients With Recurrent Clostridiodes difficile Infections?

Published in:

Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, n. 12, p. 1051, doi. 10.1093/jpids/piab112

By:

Geagan, Nicholas;
Koay, Wei Li Adeline

Publication type:

Article

Epidemiology, Diagnosis, and Treatment of Clostridioides difficile Infection in Immunocompromised Children.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, p. S46, doi. 10.1093/jpids/piab078

By:

Cross, Shane J;
Morton, Theodore H;
Wolf, Joshua

Publication type:

Article

Antibiotic Therapies for Clostridioides difficile Infection in Children.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2021, v. 10, p. S52, doi. 10.1093/jpids/piab059

By:

Gonzales-Luna, Anne J;
Carlson, Travis J;
Garey, Kevin W

Publication type:

Article

Safety and Pharmacokinetic Study of Fidaxomicin in Children With Clostridium difficile–Associated Diarrhea: A Phase 2a Multicenter Clinical Trial.

Published in:

Journal of the Pediatric Infectious Diseases Society, 2018, v. 7, n. 3, p. 210, doi. 10.1093/jpids/pix037

By:

O'Gorman, Molly A;
Michaels, Marian G;
Kaplan, Sheldon L;
Otley, Anthony;
Kociolek, Larry K;
Hoffenberg, Edward J;
Kim, Kwang Sik;
Nachman, Sharon;
Pfefferkorn, Marian D;
Sentongo, Timothy

Publication type:

Article

Fidaxomicin: A Review of Its Use in Patients with Clostridium difficile Infection.

Published in:

2013

By:

Scott, Lesley

Publication type:

Journal Article

Characterization of the impact of rpoB mutations on the in vitro and in vivo competitive fitness of Clostridium difficile and susceptibility to fidaxomicin.

Published in:

2018

By:

Kuehne, Sarah A;
Dempster, Andrew W;
Collery, Mark M;
Joshi, Nimitray;
Jowett, Jamie;
Kelly, Michelle L;
Cave, Rory;
Longshaw, Chris M;
Minton, Nigel P

Publication type:

journal article

Use of fidaxomicin through a nasogastric tube for the treatment of septic shock caused by Clostridium difficile infection in a patient with oral cancer admitted to the Surgical Critical Care Unit.

Published in:

2013

By:

Maseda, Emilio;
Hernandez-Gancedo, Carmen;
Lopez-Tofiño, Araceli;
Suarez-de-la Rica, Alejandro;
Garcia-Bujalance, Silvia;
Gilsanz, Fernando

Publication type:

Letter

Emergence and Spread of Clostridioides difficile Isolates With Reduced Fidaxomicin Susceptibility in an Acute Care Hospital.

Published in:

Clinical Infectious Diseases, 2025, v. 80, n. 5, p. 984, doi. 10.1093/cid/ciaf028

By:

Redmond, Sarah N;
Cadnum, Jennifer L;
Jencson, Annette L;
Kaple, Claire E;
Wilson, Brigid M;
Skinner, Andrew M;
Gargis, Amy S;
Hwang, Munok;
Choi, Hosoon;
Chatterjee, Piyali;
Jinadatha, Chetan;
Donskey, Curtis J

Publication type:

Article

In the Literature.

Published in:

Clinical Infectious Diseases, 2024, v. 78, n. 6, p. i, doi. 10.1093/cid/ciae277

By:

Deresinski, Stanley C

Publication type:

Article

An Open-Label, Randomized Trial Comparing Fidaxomicin With Oral Vancomycin for the Treatment of Clostridioides difficile Infection in Hospitalized Patients Receiving Concomitant Antibiotics for Concurrent Infections.

Published in:

Clinical Infectious Diseases, 2024, v. 78, n. 2, p. 277, doi. 10.1093/cid/ciad606

By:

Rao, Krishna;
Zhao, Qianzi;
Bell, Justin;
Krishnan, Jay;
Henig, Oryan;
Daniel, Jolene;
Sawaya, Kara;
Albin, Owen;
Mills, John P;
Petty, Lindsay A;
Gregg, Kevin;
Kaul, Daniel;
Malani, Anurag N;
Pogue, Jason;
Kaye, Keith S

Publication type:

Article

In the Literature.

Published in:: Clinical Infectious Diseases, 2022, v. 75, n. 8, p. i, doi. 10.1093/cid/ciac756
Publication type:: Article

Successful Fidaxomicin Hospital Discharges of Adult Patients With Clostridioides difficile Infections Post–2021 Guidelines: Are Economic Barriers Finally Coming Down?

Published in:

Clinical Infectious Diseases, 2022, v. 75, n. 3, p. 519, doi. 10.1093/cid/ciab1061

By:

Fang, Noah;
Ha, David;
Dong, Kimberly;
Leung, Thomas;
Lee, Sydney;
Holubar, Marisa;
Meng, Lina

Publication type:

Article

Medicare Prescription Plans Limit Access to Recommended Drugs for Clostridioides difficile Infection.

Published in:

Clinical Infectious Diseases, 2022, v. 74, n. 12, p. 2227, doi. 10.1093/cid/ciab898

By:

Buehrle, Deanna;
Clancy, Cornelius J

Publication type:

Article

Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile.

Published in:

Clinical Infectious Diseases, 2022, v. 74, n. 4, p. 648, doi. 10.1093/cid/ciab473

By:

Turner, Nicholas A;
Warren, Bobby G;
Gergen-Teague, Maria F;
Addison, Rachel M;
Addison, Bechtler;
Rutala, William A;
Weber, David J;
Sexton, Daniel J;
Anderson, Deverick J

Publication type:

Article

A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences.

Published in:

Clinical Infectious Diseases, 2021, v. 73, n. 6, p. 1107, doi. 10.1093/cid/ciab233

By:

Skinner, Andrew M;
Tan, Xing;
Sirbu, Benjamin D;
Danziger, Larry H;
Gerding, Dale N;
Johnson, Stuart

Publication type:

Article

Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.

Published in:

Clinical Infectious Diseases, 2021, v. 73, n. 5, p. e1029, doi. 10.1093/cid/ciab549

By:

Johnson, Stuart;
Lavergne, Valéry;
Skinner, Andrew M;
Gonzales-Luna, Anne J;
Garey, Kevin W;
Kelly, Ciaran P;
Wilcox, Mark H

Publication type:

Article

Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults.

Published in:

Clinical Infectious Diseases, 2021, v. 73, n. 5, p. 755, doi. 10.1093/cid/ciab718

By:

Johnson, Stuart;
Lavergne, Valéry;
Skinner, Andrew M;
Gonzales-Luna, Anne J;
Garey, Kevin W;
Kelly, Ciaran P;
Wilcox, Mark H

Publication type:

Article

Impact of Revised Infectious Diseases Society of America and Society for Healthcare Epidemiology of America Clinical Practice Guidelines on the Treatment of Clostridium difficile Infections in the United States.

Published in:

Clinical Infectious Diseases, 2021, v. 72, n. 11, p. 1944, doi. 10.1093/cid/ciaa484

By:

Clancy, Cornelius J;
Buehrle, Deanna;
Vu, Michelle;
Wagener, Marilyn M;
Nguyen, M Hong

Publication type:

Article

Guideline Recommendations: Optimal Timing of Publication and Resulting Rate of Adoption.

Published in:

2021

By:

Gerding, Dale N;
Johnson, Stuart

Publication type:

Editorial

Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE).

Published in:

Clinical Infectious Diseases, 2020, v. 71, n. 10, p. 2581, doi. 10.1093/cid/ciz1149

By:

Wolf, Joshua;
Kalocsai, Krisztina;
Fortuny, Claudia;
Lazar, Stefan;
Bosis, Samantha;
Korczowski, Bartosz;
Petit, Arnaud;
Bradford, Daniel;
Croos-Dabrera, Rodney;
Incera, Elodie;
Melis, Joost;
Maanen, Rob van

Publication type:

Article

Moving the Needle on Clostridioides difficile Research in Children: A Major Step Forward but Challenges Remain.

Published in:

Clinical Infectious Diseases, 2020, v. 71, n. 10, p. 2589, doi. 10.1093/cid/ciz1154

By:

Kociolek, Larry K

Publication type:

Article

Cost-effectiveness analysis of initial treatment strategies for mild-to-moderate Clostridium difficile infection in hospitalized patients.

Published in:

American Journal of Health-System Pharmacy, 2018, v. 75, n. 15, p. 1110, doi. 10.2146/ajhp170554

By:

Ford, Diana C.;
Schroeder, Mary C.;
Ince, Dilek;
Ernst, Erika J.

Publication type:

Article

Probable fidaxomicin-induced pancytopenia.

Published in:

American Journal of Health-System Pharmacy, 2018, v. 75, n. 8, p. 532, doi. 10.2146/ajhp170239

By:

Axtell, Samantha;
student, Aisha Shokoya Pharm.D.;
Yocum, Christine

Publication type:

Article

Clostridium difficile infection: A brief update on emerging therapies.

Published in:

American Journal of Health-System Pharmacy, 2015, p. 1007, doi. 10.2146/ajhp140645

By:

GOLDBERG, ERIKA J.;
BHALODIA, SUMIT;
JACOB, SHERIN;
PATEL, HATIL;
TRINH, KEN V.;
VARGHESE, BLESY;
JUNGMO YANG;
YOUNG, SEAN R.;
RAFFA, ROBERT B.

Publication type:

Article

A pharmacy concierge service to optimize fidaxomicin therapy.

Published in:

American Journal of Health-System Pharmacy, 2014, v. 71, n. 12, p. 986, doi. 10.2146/ajhp140013

By:

Bookstaver, P. Brandon;
Capino, Amanda C.;
Bookstaver, Nicole K.

Publication type:

Article

Clarifications about add-on payments for fidaxomicin.

Published in:

American Journal of Health-System Pharmacy, 2013, v. 70, n. 12, p. 1015, doi. 10.2146/ajhp120683

By:

Shah, Hemal;
Tallman, Anna M.;
Capurso, Shelley

Publication type:

Article

Fidaxomicin Compared With Oral Vancomycin for the Treatment of Severe Clostridium difficile– Associated Diarrhea: A Retrospective Review.

Published in:

Hospital Pharmacy, 2020, v. 55, n. 4, p. 268, doi. 10.1177/0018578719844165

By:

Summers, Bryant B.;
Yates, Mary;
Cleveland, Kerry O.;
Gelfand, Michael S.;
Usery, Justin

Publication type:

Article

Vigabatrin-Induced Encephalopathy; Fidaxomicin Hypersensitivity Reactions; Vemurafenib-Induced DRESS; Severe Alkalosis and Hypokalemia With Stanozolol Misuse; Isotretinoin-Associated Lip Abscess; Eltrombopag-Associated Hyperpigmentation.

Published in:

2014

By:

Mancano, Michael A.

Publication type:

Journal Article

Hit evaluation of an α-helical peptide: Ala-scan, truncation and sidechain-to-sidechain macrocyclization of an RNA polymerase Inhibitor.

Published in:

Biological Chemistry, 2019, v. 400, n. 3, p. 333, doi. 10.1515/hsz-2018-0333

By:

Kamal, Ahmed Ashraf Moustafa;
Habib, Monica;
Haupenthal, Joerg;
Hartmann, Rolf Wolfgang;
Empting, Martin

Publication type:

Article

Real-life experience with fidaxomicin in Clostridioides difficile infection: a multicentre cohort study on 244 episodes.

Published in:

Infection, 2021, v. 49, n. 3, p. 475, doi. 10.1007/s15010-020-01567-5

By:

Escudero-Sánchez, Rosa;
Valencia-Alijo, Angela;
Cuéllar Tovar, Sandra;
Merino-de Lucas, Esperanza;
García Fernández, Sergio;
Gutiérrez-Rojas, Ángela;
Ramos-Martínez, Antonio;
Salavert Lletí, Miguel;
Castro Hernández, Iván;
Giner, Livia;
Cobo, Javier

Publication type:

Article

Fidaxomicin for treatment of Clostridium difficile infection in clinical practice: a prospective cohort study in a French University Hospital.

Published in:

Infection, 2017, v. 45, n. 4, p. 425, doi. 10.1007/s15010-017-0981-8

By:

Pichenot, Marie;
Héquette-Ruz, Rozenn;
Guern, Remi;
Grandbastien, Bruno;
Charlet, Clément;
Wallet, Frédéric;
Schiettecatte, Sophie;
Loeuillet, Fanny;
Guery, Benoit;
Galperine, Tatiana

Publication type:

Article

A cost-effectiveness and budget impact analysis of first-line fidaxomicin for patients with Clostridium difficile infection (CDI) in Germany.

Published in:

Infection, 2016, v. 44, n. 5, p. 599, doi. 10.1007/s15010-016-0894-y

By:

Watt, Maureen;
McCrea, Charles;
Johal, Sukhvinder;
Posnett, John;
Nazir, Jameel

Publication type:

Article

Final Demonstration of the Co-Identity of Lipiarmycin A3 and Tiacumicin B (Fidaxomicin) through Single Crystal X-ray Analysis.

Published in:

Antibiotics (2079-6382), 2017, v. 6, n. 1, p. 7, doi. 10.3390/antibiotics6010007

By:

Serra, Stefano;
Malpezzi, Luciana;
Bedeschi, Angelo;
Fuganti, Claudio;
Fonte, Piera

Publication type:

Article

Stability and Recovery of DIFICID (Fidaxomicin) 200-mg Crushed Tablet Preparations from Three Delivery Vehicles, and Administration of an Aqueous Dispersion via Nasogastric Tube.

Published in:

Drugs in R&D, 2014, v. 14, n. 4, p. 309, doi. 10.1007/s40268-014-0067-3

By:

Tousseeva, Anna;
Jackson, J.;
Redell, Mark;
Henry, Teresa;
Hui, Michael;
Capurso, Shelley;
DeRyke, C.

Publication type:

Article

Clostridium difficile Diarrhea in the Elderly: Current Issues and Management Options.

Published in:

Drugs & Aging, 2015, v. 32, n. 8, p. 639, doi. 10.1007/s40266-015-0289-2

By:

Mizusawa, Masako;
Doron, Shira;
Gorbach, Sherwood

Publication type:

Article

Recent Progress for the Effective Prevention and Treatment of Recurrent Clostridium difficile Infection.

Published in:

Infectious Diseases: Research & Treatment, 2018, n. 11, p. 1, doi. 10.1177/1178633718758023

By:

Ramsay, Isobel;
Brown, Nicholas M.;
Enoch, David A.

Publication type:

Article

Safety and Efficacy of Fidaxomicin in Patients With Clostridium Difficile Infection.

Published in:

Clinical Medicine Insights: Therapeutics, 2013, n. 5, p. 75, doi. 10.4137/CMT.S7279

By:

Donnelley, Monica A.;
Duby, Jeremiah J.;
Cocanour, Christine S.

Publication type:

Article

Emerging therapies for Clostridium difficile infection -- focus on fidaxomicin.

Published in:

Infection & Drug Resistance, 2013, v. 6, p. 41, doi. 10.2147/IDR.S24434

By:

Chaparro-Rojas, Fredy;
Mullane, Kathleen M.

Publication type:

Article

Clostridioides Difficile: A Concise Review of Best Practices and Updates.

Published in:

Journal of Primary Care & Community Health, 2024, p. 1, doi. 10.1177/21501319241249645

By:

Yakout, Abdelrahman;
Bi, Yan;
Harris, Dana M.

Publication type:

Article

Cost-Effectiveness Analysis of Five Competing Strategies for the Management of Multiple Recurrent Community-Onset Clostridium difficile Infection in France.

Published in:

PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0170258

By:

Baro, Emilie;
Galperine, Tatiana;
Denies, Fanette;
Lannoy, Damien;
Lenne, Xavier;
Odou, Pascal;
Guery, Benoit;
Dervaux, Benoit

Publication type:

Article

Association of Fidaxomicin with C. difficile Spores: Effects of Persistence on Subsequent Spore Recovery, Outgrowth and Toxin Production.

Published in:

PLoS ONE, 2016, v. 11, n. 8, p. 1, doi. 10.1371/journal.pone.0161200

By:

Chilton, Caroline H.;
Crowther, Grace S.;
Ashwin, Helen;
Longshaw, Chris M.;
Wilcox, Mark H.

Publication type:

Article

A case of hospital-acquired pneumonia associated with Chryseobacterium indologenes infection in a patient with HIV infection and review of the literature.

Published in:

AIDS Research & Therapy, 2025, v. 22, n. 1, p. 1, doi. 10.1186/s12981-025-00749-1

By:

Mazzola, Vincenza Chiara;
Bono, Eleonora;
Pipitò, Luca;
Romanin, Benedetta;
Gioè, Claudia;
Anastasia, Antonio;
Cannella, Sara;
Virruso, Roberta;
Bonura, Celestino;
Cascio, Antonio

Publication type:

Article

Fidaxomicin (Dificid) for Clostridium difficile Infection.

Published in:

American Family Physician, 2013, v. 87, n. 3, p. 211

By:

PATEL, DHIREN;
GOLDMAN-LEVINE, JENNIFER D.

Publication type:

Article

What Every Clinician Should Know About Emerging New Antimicrobials.

Published in:

2012

By:

Vinall, Phil

Publication type:

Proceeding

Impact of the use of local fidaxomicin treatment algorithms for managing Clostridium difficile infection in hospitalized patients in southeastern United States.

Published in:

Annals of Clinical Microbiology & Antimicrobials, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12941-018-0288-3

By:

Cho, Jonathan C.;
Estrada, Sandy J.;
Kisgen, Jamie J.;
Davis, Angelina;
Puzniak, Laura

Publication type:

Article